Abraham L Bayer

14PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 01, 2026
Targeting fibroblast activation suppresses chemotherapy-induced pro-invasive remodeling of the extracellular matrix.

|Aug 27, 2026
Plasma Proteins Associated With the Immune Response to Anthracycline Cardiotoxicity in Patients With Hematologic Malignancies.

|Aug 20, 2026
Gene therapy targeting of AKAP6β-CaMKII signalosomes improves myocardial inflammation and heart failure in a swine model of cardiometabolic syndrome.

|Jun 06, 2026
STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathy.

|Dec 17, 2025
Targeting of Cdc42-Interacting Protein 4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction.

Anne-Maj Samuelsson, Abraham L Bayer, Jinliang Li

|Jun 04, 2025
Targeting of CIP4-Calcineurin Signalosomes Improves Cardiac Structure and Function After Myocardial Infarction.

Anne-Maj Samuelsson, Abraham L Bayer, Jinliang Li

Pageof 3

Frequent Collaborators

11 joint publications

Pilar Alcaide

3 joint publications

Siobhan McRee

3 joint publications

Michael S Kapiloff

3 joint publications

Kimberly L Dodge-Kafka